1. Kotfis K, Williams Roberson S, Wilson JE, Dabrowski W, Pun BT, Ely EW. COVID-19: ICU delirium management during SARS-CoV-2 pandemic. Crit Care 2020;24: 1-9. https: //doi.org/10.1186/s13054-020-02882-x [
DOI:10.1186/s13054-020-02882-x] [
PMID] [
]
2. Poorolajal J. Neglected major causes of death much deadlier than COVID-19. J Res Health Sci 2020;20(2): e00478. https: //doi.org/10.34172/jrhs.2020.13 [
DOI:10.34172/jrhs.2020.13] [
PMID] [
]
3. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA 2020;323(11): 1061-9. https: //doi.org/10.1001/jama.2020.1585 [
DOI:10.1001/jama.2020.1585] [
PMID] [
]
4. Phua J, Weng L, Ling L, Egi M, Lim CM, Divatia JV, et al. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir Med 2020;8(5): 506-17. https: //doi.org/10.1016/S2213-2600(20)30161-2 [
DOI:10.1016/S2213-2600(20)30161-2] [
PMID]
5. Mirmohammadkhani M, Paknazar F, Rashidy-pour A. Evaluation of the epidemiological pattern of COVID-19 applying basic reproduction number: An educational review article. Koomesh 2020;22(3): 273-9. https: //doi.org/10.29252/koomesh.22.3.373 [
DOI:10.29252/koomesh.22.3.373]
6. Panoutsopoulos AA. Conjunctivitis as a sentinel of SARS-CoV-2 infection: A need of revision for mild symptoms. SN Compr Clin Med 2020;2(7): 859-64. https: //doi.org/10.1007/s42399-020-00360-7 [
DOI:10.1007/s42399-020-00360-7] [
PMID] [
]
7. Team E. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)-China, 2020. China CDC weekly 2020 2;2(8): 113. https: //doi.org/10.46234/ccdcw2020.032 [
DOI:10.46234/ccdcw2020.032]
8. Lee HW, Yoon SY, Lee JK, Park TY, Kim DK, Chung HS, et al. Clinical implication and risk factor of pneumonia development in mild coronavirus disease 2019 patients. Korean J Intern Med 2021;36(1): 1-10. https: //doi.org/10.3904/kjim.1990.5.1.1 [
DOI:10.3904/kjim.2020.329] [
PMID] [
]
9. Giraud R, Bendjelid K. COVID-19 pandemic: A new path to intensive care medicine distinction? Anaesth Crit Care Pain Med 2020;39(5): 545-6. https: //doi.org/10.1016/j.accpm.2020.07.010 [
DOI:10.1016/j.accpm.2020.07.010] [
PMID] [
]
10. National Institutes of Health (US) COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health; 2021 Apr. [
URL]
11. Sprung CL, Joynt GM, Christian MD, Truog RD, Rello J, Nates JL. Adult ICU triage during the Coronavirus disease 2019 pandemic: Who will live and who will die? Recommendations to improve survival. Crit Care Med 2020. https: //doi.org/10.1097/CCM.0000000000004410 [
DOI:10.1097/CCM.0000000000004410] [
PMID] [
]
12. Li J, Tian A, Yang D, Zhang M, Chen L, Wen J, et al. Celiac disease and the susceptibility of COVID-19 and the risk of severe COVID-19: A Mendelian randomization study. Clin Transl Gastroenterol 2022;13(5): e00480. https: //doi.org/10.14309/ctg.0000000000000480 [
DOI:10.14309/ctg.0000000000000480] [
PMID] [
]
13. Pande D, Kochhar A, Saini S, Ganapathy U, Gogia AR. An update on initial epidemiological profile, clinical course, and outcome of COVID-19 patients at a tertiary care center in India. Indian J Palliat Care 2020;26(Suppl 1): S36-9. https: //doi.org/10.4103/IJPC.IJPC_146_20 [
DOI:10.4103/IJPC.IJPC_146_20] [
PMID] [
]
14. Calmes D, Graff S, Maes N, Frix AN, Thys M, Bonhomme O, et al. Asthma and COPD are not risk factors for ICU stay and death in case of SARS-CoV2 infection. J Allergy Clin Immunol Pract 2021;9(1): 160-9. https: //doi.org/10.1016/j.jaip.2020.09.044 [
DOI:10.1016/j.jaip.2020.09.044] [
PMID] [
]
15. Halim AA, Alsayed B, Embarak S, Yaseen T, Dabbous S. Clinical characteristics and outcome of ICU admitted MERS corona virus infected patients. Egypt J Chest Dis Tuberc 2016;65(1): 81-7. https: //doi.org/10.1016/j.ejcdt.2015.11.011 [
DOI:10.1016/j.ejcdt.2015.11.011] [
PMID] [
]
16. Jha M, Tak ML, Gupta R, Sharma P, Rajpurohit V, Mathur P, et al. Relationship of anemia with COVID-19 deaths: A retrospective cross-sectional study. J Anaesthesiol Clin Pharmacol 2022;38(Suppl 1): S115-9. https: //doi.org/10.4103/joacp.joacp_63_22 [
DOI:10.4103/joacp.joacp_63_22] [
PMID] [
]
17. Sevim M, Alkiş O, Kartal İG, Coşer Ş, Akman H, Aras B. Impact of COVID-19 on the progression of benign prostatic hyperplasia and aggravation of related symptoms: A prospective study. Prostate 2023;83(1): 82-6. https: //doi.org/10.1002/pros.24439 [
DOI:10.1002/pros.24439] [
PMID] [
]
18. Vahedi A, Tabasi F, Monjazebi F, Hashemian SMR, Tabarsi P, Farzanegan B, et al. Clinical features and outcomes of ICU patients with COVID-19 infection in Tehran, Iran: A single-centered retrospective cohort study. Tanaffos 2020;19(4): 300-11. [
PMID]
19. Cao J, Tu WT, Cheng W, Yu L, Liu K, Hu X, et al. Clinical Features and Short-term Outcomes of 102 Patients wit Coronavirus Disease. Clin Infec Dis 2019;71(15): 757. https: //doi.org/10.1093/cid/ciaa243 [
DOI:10.1093/cid/ciaa243] [
PMID] [
]
20. Ronderos D, Omar AMS, Abbas H, Makker J, Baiomi A, Sun H, et al. Chronic hepatitis-C infection in COVID-19 patients is associated with in-hospital mortality. World J Clin Cases 2021;9(29): 8749-62. https: //doi.org/10.12998/wjcc.v9.i29.8749 [
DOI:10.12998/wjcc.v9.i29.8749] [
PMID] [
]
21. Wu B, Zhou JH, Wang WX, Yang HL, Xia M, Zhang BH, et al. Association analysis of hyperlipidemia with the 28-day all-cause mortality of COVID-19 in hospitalized patients. Chin Med Sci J 2021;36(1): 17-26. [
Google Scholar]
22. Benoit JL, Benoit SW, de Oliveira MHS, Lippi G, Henry BM. Anemia and COVID-19: A prospective perspective. J Med Virol 2021;93(2): 708-11. https: //doi.org/10.1002/jmv.26530 [
DOI:10.1002/jmv.26530] [
PMID] [
]
23. Atmaca A, Demirci I, Haymana C, Tasci I, Sahin I, Cakal E, et al. No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study. Osteoporos Int 2022;33(1): 273-82. https: //doi.org/10.1007/s00198-021-06067-2 [
DOI:10.1007/s00198-021-06067-2] [
PMID] [
]